Replies to post #498276 on NorthWest Biotherapeutics Inc (NWBO)

[Smokey21]

Agree with your assessment Kab. I think they will issue enough to cover payment of the note payments due in August, and any other needed operating Capital needed. I think people believed they were in a box and had to vote to increase common before then. Apparently we have just bought a few months before that happens. Linda never ceases to pull a rabbit out of the hat, just when you think she’s out of them.

[10baggerz]

100% agree, and unless they’ve had no plan whatsoever for the past 2 years and are simply desperate for financing, they probably won’t sell these preferred shares at $16.xx (.64 common).

Still, IF there isn’t news in the premarket, the timing of this filing is yet another befuddling action by management (akin to not updating clinical trials before 5/10). We are near a 100 week closing low, we desperately need good news for any sustainable share price increase and what do they do?

Pre-dilute 250,000,000 shares that have not even been authorized yet by shareholders. One thing is for sure, tomorrow will NOT be another low volume walk down day.

[iwasadiver]

I think it’s interesting they’re series C.

[sentiment_stocks]

Thanks, Kab! I should add that despite the fact that these pref Cs have 25x voting power, it’s simply because each pref share is comprised of the price of 25 shares. Had those shares simply been purchased, the buyer would have walked away with 25 common shares, and instead, the buyers agreed to tie up those same 25 shares in ComputerShare as a single pref C share that cannot be sold for now.

[iwasadiver]

As I’ve said; I think they went to series C because some big money wants a taste. The voting issue however is unusual, so it adds some intrigue for me. They def don’t want to dilute and this is the perfect strategy for right now because any dilution is 1/25th of what it would be at current price…for now. When they convert the dilution increases. But, at that time it won’t matter. There’s definitely more to this story but the baseline is a little money right now with little dilution. The after party is something different me thinks.

[biosectinvestor]

Agreed Senti and Kabunushi. They are authorized and not issued and this provides them with a tool to negotiate a deal at this stage.

[AngeloFoca]

This 8-k is very interesting but until they announce any sale of the pref C shares we have no information as to how much they intend to raise in the near term.

Assuming... the average price is 64 cents... (not likely) they could raise $160 million for the lot.

I don't believe they would EVER have to raise money again.

It may well be a means by which it allows large buy ins without significantly affecting the price.





.